Blood Protein as Youth Rejuvenator

Researchers identify a component of young mouse blood that can help repair damaged brains and muscles in older mice.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, RAMAScientists have known for a few years that blood from young mice could rejuvenate aging blood stem cells in older mice. And last year, a protein called growth differentiation factor 11 (GDF11), which is much more abundant in the blood of younger mice than in older mice, was shown to reverse cardiac hypertrophy—age-related swelling and thickening of heart cells that can cause heart failure. Now, two teams of researchers have found that GDF11 can aid in more widespread muscle regeneration and in the repair of age-related brain cell damage. “I am extremely excited,” Rudolph Tanzi, a neurologist at Harvard Medical School who was not involved in the research, told The New York Times. “These findings could be a game changer.”

In a pair of studies published yesterday (May 5) in Science, Harvard University stem cell researcher Amy Wagers and colleagues reported that GDF11 could repair aged muscle tissue in older mice and could enhance neurogenesis and improve cerebral vasculature in aging mice. The hope is that the human form of the protein may have similar anti-aging affects in humans, although more research is required before that treatment becomes a clinical reality. “I believe there's still some very important pre-clinical work we need to do, including understanding why GDF11 is lost with age, and whether there is counter-regulation of it that may develop in older mice,” Wagers told New Scientist. “I think we can answer those questions in the next three to five years and be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies